Propranolol Hydrochloride (Hemangiol) [Internet].

Infantile hemangiomas (IHs) are the most common vascular tumours occurring in children. The incidence and prevalence of IH in Canada is uncertain; however, the manufacturer has estimated that the incidence of IH ranges from 4.5% to 10.0%. Hemangiol is an oral solution containing 3.75 mg/mL propranolol that is indicated for the treatment of proliferating IH requiring systemic therapy in the following circumstances: life- or function-threatening hemangioma; ulcerated hemangioma with pain and/or lack of response to simple wound care measures; or hemangioma with a risk of permanent scarring or disfigurement. The manufacturer has requested that propranolol oral solution receive a recommendation to reimburse in accordance with the Health Canada–approved indication.

http://ift.tt/2DChPhq